BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 31150958)

  • 1. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
    Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.
    Chung SJ; Lee YH; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2019 Sep; 66():105-109. PubMed ID: 31324555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is white matter hyperintensity burden associated with cognitive and motor impairment in patients with parkinson's disease? A systematic review and meta-analysis.
    Carvalho de Abreu DC; Pieruccini-Faria F; Son S; Montero-Odasso M; Camicioli R
    Neurosci Biobehav Rev; 2024 Jun; 161():105677. PubMed ID: 38636832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
    Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
    Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
    Huang X; Wen MC; Ng SY; Hartono S; Chia NS; Choi X; Tay KY; Au WL; Chan LL; Tan EK; Tan LC
    Eur J Neurol; 2020 Jun; 27(6):959-966. PubMed ID: 32124496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal White Matter Damage Evolution in Parkinson's Disease.
    Scamarcia PG; Agosta F; Spinelli EG; Basaia S; Stojković T; Stankovic I; Sarasso E; Canu E; Markovic V; Petrović I; Stefanova E; Pagani E; Kostic VS; Filippi M
    Mov Disord; 2022 Feb; 37(2):315-324. PubMed ID: 34806799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.
    Lee YH; Lee WJ; Chung SJ; Yoo HS; Jung JH; Baik K; Sohn YH; Seong JK; Lee PH
    J Parkinsons Dis; 2021; 11(1):239-249. PubMed ID: 33074193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
    Chen HM; Zhang MM; Wang YL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional white matter hyperintensity volume in Parkinson's disease and associations with the motor signs.
    Wu H; Hong H; Wu C; Qin J; Zhou C; Tan S; DuanMu X; Guan X; Bai X; Guo T; Wu J; Chen J; Wen J; Cao Z; Gao T; Gu L; Huang P; Xu X; Zhang B; Zhang M
    Ann Clin Transl Neurol; 2023 Sep; 10(9):1502-1512. PubMed ID: 37353980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
    Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
    Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease.
    Dadar M; Miyasaki J; Duchesne S; Camicioli R
    Parkinsonism Relat Disord; 2021 Apr; 85():95-101. PubMed ID: 33770671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.